Carfilzomib, Pomalidomide, and Dexamethasone As Second‐line Therapy for Lenalidomide‐refractory Multiple Myeloma
Sonneveld, Pieter, Zweegman, Sonja, Cavo, Michele, Nasserinejad, Kazem, Broijl, Annemiek, Troia, Rosella, Pour, Ludek, Croockewit, Sandra, Corradini, Paolo, Patriarca, Francesca, Wu, Kalung, Droogendijk, Jolanda, Bos, Gerard, Hajek, Roman, Teresa Petrucci, Maria, Ypma, Paula, Zojer, Nicholas, Minnema, Monique C., Boccadoro, Mario
Published in HemaSphere (01.10.2022)
Published in HemaSphere (01.10.2022)
Get full text
Journal Article